HIV/AIDS Anti-Diarrheal Drug Fulyzaq (Crofelemer) Approved By FDA
The first anti-diarrheal drug for HIV/AIDS patients, Fulyzaq (crofelemer 125 mg delayed-release tablets), has been approved by the FDA (Food Source: Health News
Continue Reading →Posted in: AICHC News
Leave a Comment (0) →